Heimes, B., Schick, T., Brinkmann, C. K., Wiedon, A., Haegele, B., Kirchhof, B., Holz, F. G., Pauleikhoff, D., Ziemssen, F., Liakopoulos, S., Spital, G. and Schmitz-Valckenberg, S. (2016). Design of the ORCA module in the OCEAN study. Evaluation of SD-OCT results in daily routine practice. Ophthalmologe, 113 (7). S. 570 - 581. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0423

Full text not available from this repository.

Abstract

The prevalence of blindness as defined by law could be reduced by the introduction of anti-vascular endothelial growth factor (VEGF) therapy. Because the treatment is governed by patient needs, mostly using morphological criteria, imaging diagnostics are of particular importance. The non-interventional OCEAN study investigates the treatment with ranibizumab in the clinical routine practice. In a subgroup of patients the interpretation of spectral domain optical coherence tomography (SD-OCT) scans by the treating physicians will be analyzed (ORCA module). Over a period of 24 months data from patients with exudative age-related macular degeneration (AMD), macular edema due to retinal vein occlusion or diabetes mellitus, who are receiving intravitreal injections of ranibizumab, will be assessed. Information on examinations, visual acuity, treatment and recordings from imaging techniques will be documented using a questionnaire. The SD-OCT scans, fluorescence angiography and fundus photography will be independently analyzed by the ophthalmologist of the study center and by three reading centers (CIRCL Cologne, GRADE Bonn and M3 Munster). Automated measurements of retinal thickness by the manufacturers' software will be checked and if necessary manually corrected. A qualitative interpretation in terms of morphological criteria for (further) treatment will be performed. A thorough assessment of SD-OCT images during anti-VEGF therapy provides the basis for the best possible needs-oriented treatment regimen. The control of the quality of data from daily routine practice may indicate possible weaknesses allowing explicit training and therefore optimization of patient treatment.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Heimes, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schick, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Brinkmann, C. K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiedon, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Haegele, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kirchhof, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Holz, F. G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pauleikhoff, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ziemssen, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Liakopoulos, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Spital, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmitz-Valckenberg, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-271709
DOI: 10.1007/s00347-016-0224-x
Journal or Publication Title: Ophthalmologe
Volume: 113
Number: 7
Page Range: S. 570 - 581
Date: 2016
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1433-0423
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
GROWTH-FACTOR THERAPY; MACULAR DEGENERATION; VISUAL IMPAIRMENT; BLINDNESSMultiple languages
OphthalmologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/27170

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item